Template:DN4: Difference between revisions

From WikiMSK

No edit summary
No edit summary
 
Line 69: Line 69:
|<html><input class="start-item" id="q10-y" name="ten" type="radio" value="0" onclick="window.startScore(this);" /></html>
|<html><input class="start-item" id="q10-y" name="ten" type="radio" value="0" onclick="window.startScore(this);" /></html>
|-
|-
! colspan="3" |<div style="display:flex; flex-direction:row; justify-content:space-around;"><div>Result</div><div><span class="interpretation" style="color: green;">Negative</span></div><div><span class="score">Score: 0</span></div></div>
! colspan="3" |<div style="display:flex; flex-direction:row; justify-content:space-around;"><div>Result</div><div><span class="interpretation" style="color: green;">Negative</span></div><div><span class="score">Score: 0/10</span></div></div>
|-
|-
|colspan="3"|<small>Validated in painful diabetic polyneuropathy. At the cut-off of 4, DN4 displayed sensitivity of 80%, specificity of 92%, positive predictive value (PPV) of 82%, negative predictive value (NPV) of 91%, and likelihood ratio for a positive result (LR(+) ) of 9.6. At the cut-off of 3, DN4-interview showed sensitivity and specificity of 84%, PPV of 71%, NPV of 92%, and LR(+) of 5.3.<ref>Spallone V, Morganti R, D'Amato C, Greco C, Cacciotti L, Marfia GA. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med. 2012 May;29(5):578-85. doi: 10.1111/j.1464-5491.2011.03500.x. [https://pubmed.ncbi.nlm.nih.gov/22023377/#:~:text=Aims%3A%20DN4%20(Douleur%20Neuropathique%20en,formally%20been%20validated%20in%20diabetes. PMID]</ref></small>
|colspan="3"|<small>Validated in painful diabetic polyneuropathy. At the cut-off of 4, DN4 displayed sensitivity of 80%, specificity of 92%, positive predictive value (PPV) of 82%, negative predictive value (NPV) of 91%, and likelihood ratio for a positive result (LR(+) ) of 9.6. At the cut-off of 3, DN4-interview showed sensitivity and specificity of 84%, PPV of 71%, NPV of 92%, and LR(+) of 5.3.<ref>Spallone V, Morganti R, D'Amato C, Greco C, Cacciotti L, Marfia GA. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med. 2012 May;29(5):578-85. doi: 10.1111/j.1464-5491.2011.03500.x. [https://pubmed.ncbi.nlm.nih.gov/22023377/#:~:text=Aims%3A%20DN4%20(Douleur%20Neuropathique%20en,formally%20been%20validated%20in%20diabetes. PMID]</ref></small>
Line 90: Line 90:
   else if(score >3){ $(element).css("color", "red").html("Positive");}
   else if(score >3){ $(element).css("color", "red").html("Positive");}
   else { $(element).css("color", "red").html("Error"); }
   else { $(element).css("color", "red").html("Error"); }
   $('.score').html('Score: ' + score)
   $('.score').html('Score: ' + score + '/10')
  }
  }
}
}
</script></html></div>
</script></html></div>
<noinclude>[[Category:Calculators]]</noinclude>
<noinclude>[[Category:Calculators]]</noinclude>

Latest revision as of 14:48, 6 April 2022

DN4 - Questionnaire
INTERVIEW OF THE PATIENT
QUESTION 1
Does the pain have one or more of the following characteristics? Yes No
Burning
Painful cold
Electric shocks
QUESTION 2
Is the pain associated with one or more of the following symptoms in the same area? Yes No
Tingling
Pins and needles
Numbness
Itching
EXAMINATION OF THE PATIENT
QUESTION 3
Is the pain located in an area where the physical examination may reveal one or more of the following characteristics? Yes No
Hypoaesthesia to touch
Hypoaesthesia to pinprick
QUESTION 4
In the painful area, can the pain be caused or increased by: Yes No
Brushing
Result
Negative
Score: 0/10
Validated in painful diabetic polyneuropathy. At the cut-off of 4, DN4 displayed sensitivity of 80%, specificity of 92%, positive predictive value (PPV) of 82%, negative predictive value (NPV) of 91%, and likelihood ratio for a positive result (LR(+) ) of 9.6. At the cut-off of 3, DN4-interview showed sensitivity and specificity of 84%, PPV of 71%, NPV of 92%, and LR(+) of 5.3.[1]
  1. Spallone V, Morganti R, D'Amato C, Greco C, Cacciotti L, Marfia GA. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med. 2012 May;29(5):578-85. doi: 10.1111/j.1464-5491.2011.03500.x. PMID